Insulin half-life in man after trauma. 1981

M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden

To explore the possibility that the half-life of insulin changes after trauma, five control subjects and 19 severe trauma patients received intravenous glucose (0.5 gm/kg) in 5 minutes to raise rapidly the insulin levels, followed immediately by 300 mg of intravenous diazoxide over 5 minutes to inhibit any further insulin secretion. Serial blood samples were analyzed for immunoreactive insulin, and insulin half-life was calculated. The baseline insulin level was 13.4 +/- 3.8 microU/ml in the trauma group 10.4 +/- 3.1 microU/ml in the control group. During the glucose infusion, insulin levels rose to 177.0 +/- 56.0 microU/ml in the controls and to 127.0 +/- 27.0 microU/ml in the trauma group. The rise in the control subjects was greater (P less than 0.03) than the rise in the trauma patients. After diazoxide, insulin levels fell to 25.0 +/- 6.2 microU/ml and 25.0 +/- 6.6 microU/ml, respectively. Insulin half-life in the control subjects was 5.2 +/- 0.3 min and 3.9 +/- 0.2 min in the trauma group (P less than 0.019).

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
November 1968, Metabolism: clinical and experimental,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
June 1974, Journal of pharmacokinetics and biopharmaceutics,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
June 1986, Surgery,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
December 1959, Nature,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
December 1968, Health physics,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
July 1985, Clinical endocrinology,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
April 1975, Annals of clinical research,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
September 1972, Health physics,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
November 1977, Clinical pharmacology and therapeutics,
M M Meguid, and F Aun, and J S Soeldner, and D A Albertson, and C M Boyden
January 1983, Therapie,
Copied contents to your clipboard!